Literature DB >> 17854728

Hepatitis C meanings and preventive strategies among street-involved young injection drug users in Montréal.

Elise Roy1, Eva Nonn, Nancy Haley, Joseph Cox.   

Abstract

OBJECTIVE: To examine what hepatitis C virus (HCV) infection means to street-involved young IDUs (SYIDUs) and how this impacts on their health behaviours, based on social contexts in which they live.
METHODS: Thirty-nine SYIDUs with HCV infection participated in in-depth interviews. A typology was built founded on SYIDUs' street life and drug use experiences. The meanings given to hepatitis C and resulting health behaviours were examined through these experiences.
RESULTS: In Montréal, "total" experience is characterised by an exclusive social relationship with the street milieu and by intensive drug consumption. In this milieu, where most injectors are HCV-infected but asymptomatic, getting infected is considered trivial. Compared to other more immediate threats, HCV infection and its long-term consequences are lesser concerns. Efforts to inject safely are made to avoid HIV. When these SYIDUs learn they are HCV-infected, they do not make important lifestyle changes. However, since they worry about transmitting the infection to others, they notify their injection partners that they are infected. SYIDUs living a "controlled" experience preserve some stability in their lives and control their consumption. They maintain relationships within mainstream society and have beliefs reflecting these links. They view HCV infection as a serious disease and make significant efforts to avoid sharing their injection equipment and thus remain healthy. When they learn they are HCV-infected, they engage in "liver friendly" behaviours but are not ready to stop injecting. The "disengaging" experience is that of youth who start to disengage from drug injection. They leave the drug milieu and develop new relationships within mainstream society. They adopt new values regarding health. HCV infection is viewed as requiring significant changes in strategies aimed at protecting themselves and others.
CONCLUSION: This research sheds light on the fundamentally social nature of hepatitis C. SYIDUs' HCV experiences, which evolve in parallel with their street life and consumption trajectories, provide numerous occasions where they can be exposed to prevention messages.

Entities:  

Mesh:

Year:  2007        PMID: 17854728     DOI: 10.1016/j.drugpo.2007.02.005

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  10 in total

1.  HIV and HCV discordant injecting partners and their association to drug equipment sharing.

Authors:  Prithwish De; Joseph Cox; Jean-Francois Boivin; Robert W Platt; Ann M Jolly; Paul E Alexander
Journal:  Scand J Infect Dis       Date:  2009

2.  A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs.

Authors:  T Spelman; M D Morris; G Zang; T Rice; K Page; L Maher; A Lloyd; J Grebely; G J Dore; A Y Kim; N H Shoukry; M Hellard; J Bruneau
Journal:  J Epidemiol Community Health       Date:  2015-03-26       Impact factor: 3.710

3.  Prevalence of HCV risk behaviors among prison inmates: tattooing and injection drug use.

Authors:  Marisol Peña-Orellana; Adriana Hernández-Viver; Glorimar Caraballo-Correa; Carmen E Albizu-García
Journal:  J Health Care Poor Underserved       Date:  2011-08

4.  Hepatitis C virus risk behaviors within the partnerships of young injecting drug users.

Authors:  Judith A Hahn; Jennifer L Evans; Peter J Davidson; Paula J Lum; Kimberly Page
Journal:  Addiction       Date:  2010-05-14       Impact factor: 6.526

5.  Characterization of HCV-infected people who inject drugs (PWID) in the setting of clinical care in Canada (CAPICA): A retrospective study.

Authors:  Brian Conway; Julie Bruneau; Curtis Cooper; Chris Steingart; Chris Fraser; Kris Stewart; Lucie Deshaies; Réjean Thomas; Duncan Webster; Gisela Macphail; Jeff Powis; Joseph Cox; Jordan J Feld; Mark E McGovern; Janie B Trepanier; Martine Drolet
Journal:  Can Liver J       Date:  2020-11-17

6.  Economically Efficient Hepatitis C Virus Treatment Prioritization Improves Health Outcomes.

Authors:  Lauren E Cipriano; Shan Liu; Kaspar S Shahzada; Mark Holodniy; Jeremy D Goldhaber-Fiebert
Journal:  Med Decis Making       Date:  2018-08-22       Impact factor: 2.583

Review 7.  The ongoing impacts of hepatitis c--a systematic narrative review of the literature.

Authors:  Emma R Miller; Stephen McNally; Jack Wallace; Marisa Schlichthorst
Journal:  BMC Public Health       Date:  2012-08-18       Impact factor: 3.295

8.  Hepatitis C avoidance in injection drug users: a typology of possible protective practices.

Authors:  Catherine McGowan; Magdalena Harris; Tim Rhodes
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

9.  Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA.

Authors:  Meghan D Morris; Jennifer Evans; Martha Montgomery; Michelle Yu; Alya Briceno; Kimberly Page; Judith A Hahn
Journal:  PLoS One       Date:  2014-10-06       Impact factor: 3.240

10.  HCV incidence is associated with injecting partner age and HCV serostatus mixing in young adults who inject drugs in San Francisco.

Authors:  Kimberly Page; Jennifer L Evans; Judith A Hahn; Peter Vickerman; Stephen Shiboski; Meghan D Morris
Journal:  PLoS One       Date:  2019-12-10       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.